Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025
Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.
Buyer
United Lincolnshire Teaching Hospitals NHS Trust
Value
£105,600
Published
24 Jan 2025
Closes
16 Dec 2024
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Goods
Contract starts
1 Jan 2025
Contract ends
31 Dec 2025
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025
£105,600
Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
24 Jan 2025
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.